CAPVAXIVE
NDC 0006-4347, Pneumococcal 21-valent Conjugate Vaccine, injection, solution, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-4347
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125814
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4347 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 15A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE DEOAC15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 16F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 20A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 23A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 23B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 24F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 31 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- STREPTOCOCCUS PNEUMONIAE TYPE 35B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN4 ug/.5mL
- CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN65 ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Inactivated Pneumococcal Vaccine [EPC]; Inactivated Pneumococcal Vaccine [EPC]; Inactivated Pneumococcal Vaccine [EPC]; Inactivated Pneumococcal Vaccine [EPC]; Pneumococcal Vaccines [CS]; Pneumococcal Vaccines [CS]; Pneumococcal Vaccines [CS]; Pneumococcal Vaccines [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-4347-01 | 00006434701 | 1 SYRINGE in 1 CARTON (0006-4347-01) / .5 mL in 1 SYRINGE (0006-4347-99) |
| 0006-4347-02 | 00006434702 | 10 SYRINGE in 1 CARTON (0006-4347-02) / .5 mL in 1 SYRINGE (0006-4347-99) |
Linked data
RxNorm, label and prices
Use it
Look up 0006-4347 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4347 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-4347. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.